![](/wp-content/uploads/2021/04/xhome-01.png.pagespeed.ic.gekUBU5A4F.jpg)
Envisioning the future of atherosclerosis treatment
HDL Therapeutics is revolutionizing the way that patients with atherosclerosis not only manage their disease, but treat it.
![](http://new.hdltherapeutics.com/wp-content/uploads/2021/04/home-02.png)
Novel Approach
We are going where no one has gone before. Our PDS-2™ System is the only FDA-approved therapy designed to harness the power of HDL (“good cholesterol”) levels to regress plaques in the coronary arteries of patients with HoFH.
![](http://new.hdltherapeutics.com/wp-content/uploads/2021/04/home-02.png)
![](http://new.hdltherapeutics.com/wp-content/uploads/2021/04/home-03.png)
Expert Leadership
HDL Therapeutics brings together expert talent with decades of experience in the pharmaceutical, biotechnology, and medical device industries.